Allopurinol and Quality of Life

• Status: Recruiting
• Trial end date: 2023-05-15
• Target enrollment: 0
• Participant gender: All

Summary

The study aims to evaluate the impact of allopurinol on patients' related quality of life.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tanta University
• Treatments: Allopurinol

Criteria

Inclusion Criteria:

cirrhosis adult both sex

Exclusion Criteria:

• renal insufficiency